---
layout: default
title: Artenimol
parent: 僅模型預測 (L5)
nav_order: 27
evidence_level: L5
indication_count: 0
---

# Artenimol
{: .fs-9 }

證據等級: **L5** | 預測適應症: **0** 個
{: .fs-6 .fw-300 }

---

## 目錄
{: .no_toc .text-delta }

1. TOC
{:toc}

---

<div id="pharmacist">

## 藥師評估報告

</div>

# Artenimol (DB11638): Evidence Pack Incomplete — Repurposing Evaluation Pending

## One-Sentence Summary

Artenimol (DrugBank ID: DB11638) is currently **not approved or marketed in Taiwan**, and the Evidence Pack contains **no TxGNN-predicted new indications**, no mechanism of action data, and no safety records. A full repurposing evaluation cannot be completed until the required data gaps are resolved.

---

## Quick Overview

| Item | Content |
|------|---------|
| Original Indication | Not available in current data |
| Predicted New Indication | No predictions generated |
| TxGNN Prediction Score | N/A |
| Evidence Level | N/A |
| Taiwan Market Status | ✗ Not marketed |
| Number of Authorizations | 0 |
| Recommended Decision | **Hold** |

---

## Safety Considerations

Please refer to the package insert for safety information.

---

## Conclusion and Next Steps

**Decision: Hold**

**Rationale:**
The Evidence Pack for Artenimol is critically incomplete — no TxGNN repurposing predictions were generated, and both mechanism of action and safety data are absent. There is no actionable evidence on which to base a repurposing recommendation.

**To proceed, the following is needed:**

- **[Blocking] TFDA package insert warnings and contraindications** — download and parse the PDF from the TFDA website to enable safety pre-screening (DG001)
- **[High] Mechanism of action (MOA)** — query DrugBank API for DB11638 to enable mechanistic plausibility analysis (DG002)
- **TxGNN prediction results** — the `predicted_indications` array is empty; confirm whether the drug was processed through the TxGNN pipeline and re-run if necessary
- **Original indication data** — the `original_indications` field is empty; verify source data completeness before re-querying
## Disclaimer

This content is for research purposes only and does not constitute medical advice.
Clinical validation is required before any clinical application.

---

